NASDAQ:CLPT
ClearPoint Neuro, Inc.
ClearPoint Neuro, Inc.'s revenue grew 17.8% in fiscal 2025 to $37.0M while operating margin fell to −65.4%. Free cash flow was −$24.4M, −66.1% of revenue, and the diluted share count rose 4.8%.Summary generated from ClearPoint Neuro, Inc.'s SEC filings. Latest annual report filed Mar 17, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$37.0M
Revenue growth+17.8%
Revenue, 5-yr CAGR+23.6%
Gross margin61.4%
Operating margin−65.4%
Net margin−69.1%
ROICn/a
Return on equity−95.6%
Debt / equity1.75
Free cash flow−$24.4M
FCF margin−66.1%
Share count change+4.8%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 16 | 21 | 24 | 31 | 37 |
| Operating income | −13 | −16 | −22 | −20 | −24 |
| Net income | −14 | −16 | −22 | −19 | −26 |
| Free cash flow | −13 | −16 | −14 | −9 | −24 |
Recent filings
- 4Insider transaction report
Oct 2, 2026 - 4Insider transaction report
Oct 2, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 3, 2026 - 8-KResults of operations and financial condition
Aug 3, 2026 - 8-KDirector or officer change
May 21, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 13, 2026 - 8-KResults of operations and financial condition
May 13, 2026 - DEF 14AProxy statement
Apr 10, 2026